Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "GenBioPro"


6 mentions found


The abortion pill manufacturer GenBioPro on Wednesday sued to overturn West Virginia's ban on abortion because it restricts access to a medication approved by the Food and Drug Administration. The lawsuit, filed in federal court in West Virginia's southern district, argues that FDA regulations on medications such as the abortion pill pre-empt state law under the U.S. Constitution. Access to the pill, called mifepristone, has become a major legal battleground in the wake of the Supreme Court ruling that overturned federal abortion rights last June. A dozen states, including West Virginia, have implemented near total abortion bans that basically outlaw the use of mifepristone. But bans such as those in West Virginia conflict with FDA regulations on mifepristone, raising the question of whether federal or state laws take precedence.
Companies Genbiopro Inc FollowJan 25 (Reuters) - A maker of abortion pills and a doctor have filed lawsuits challenging state restrictions on the medication, in the first lawsuits of their kind since the U.S. Supreme Court overturned the federal constitutional right to abortion. The doctor, Amy Bryant, filed a separate lawsuit in the federal court in Durham, North Carolina, challenging state-imposed restrictions on obtaining mifepristone, which she said impeded her ability to treat patients. Medication abortions make up more than half of U.S. abortions. Misoprostol is the second drug of the two-drug regimen for medication abortion. Twelve states now ban nearly all abortions, including medication abortions.
Bryant objected to North Carolina requirements that patients obtain abortion pills only in person from physicians in specially certified facilities, and undergo as state-mandated counseling at least 72 hours before having abortions. The offices of West Virginia Attorney General Patrick Morrisey and North Carolina Attorney General Josh Stein did not immediately respond to requests for comment. The West Virginia lawsuit was reported earlier by The New York Times, and the North Carolina lawsuit by ABC News. The cases are GenBioPro Inc v Sorsaia et al, U.S. District Court, Southern District of West Virginia, No. 23-00058; and Bryant v Stein et al, U.S. District Court, Middle District of North Carolina, No.
Jan 6 (Reuters) - Pharmacies across the United States are weighing whether to sell mifepristone, a pill used in medication abortions, following the Food and Drug Administration's announcement earlier this week that they can now do so. The FDA rule will make medication abortion, which accounts for more than half of U.S. abortions, more accessible in states where abortion remains legal, but its impact on pharmacies in the states that have banned abortion remains to be seen. The pharmacy is located near Florida's borders with Georgia and Alabama, where abortion is severely restricted. We're not near an abortion clinic or in a larger city where that happens more," she said. Steve Moore, pharmacist and owner of Condo Pharmacy in Plattsburgh, New York, a state where abortion is legal, plans to dispense the drug.
Walgreens, CVS plan to start offering abortion pills
  + stars: | 2023-01-05 | by ( ) www.reuters.com   time to read: +2 min
Jan 4 (Reuters) - Walgreens Boot Alliance Inc (WBA.O) and CVS Health Corp (CVS.N) said on Wednesday they plan to offer abortion pills following the U.S. Food and Drug Administration's (FDA) decision to allow retail pharmacies to offer the drug in the country for the first time. U.S. abortion rights were curtailed in 2022 when the U.S. Supreme Court overturned the landmark 1973 Roe vs. Wade decision. Medication abortion accounts for more than half of U.S. abortions. The decision will make the medication more accessible in states where abortion remains legal, but its impact in states that have banned abortion will be limited. CVS shares fell 1% in regular U.S. trading on Tuesday; Walgreens shares rose 0.8%.
WASHINGTON, Jan 3 (Reuters) - Retail pharmacies will now be allowed to offer abortion pills in the United States under a regulatory change made by the Food and Drug Administration on Tuesday, the two companies that make the pills said on Tuesday. Pharmacies can apply for certification to distribute mifepristone with the drugmakers and if successful will be able to dispense it directly to patients upon receiving a prescription from a certified prescriber, said Danco Laboratories, one of two companies that make mifepristone. The announcement will not provide equal access to all people, however, GenBioPro, which makes the generic version of mifepristone, said in a statement. Retail pharmacies will have to weigh whether or not to offer the pill and determine where they can do so. Reporting by Eric Beech and Ahmed Aboulenein in Washington, Shivani Tanna and Rahat Sandhu in Bengaluru; Editing by Himani SarkarOur Standards: The Thomson Reuters Trust Principles.
Total: 6